GTR Home > Tests > Search results - Primary hyperoxaluria, type I

Apply filters

Showing test for 1 condition

reset

Compare labs

Your search term can be found in tests with a total of 1156 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

More test methods
  • Hide states
More locations

GTR test search results for C0268164[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 26 tests for 1 condition in 21 labs

CPrimary hyperoxaluria type 1

Test targets
Methods
  • A Analyte
  • E Enzyme assay
  • C Sequence analysis of the entire coding region

CHyperoxaluria primary type I

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CPrimary Hyperoxaluria Type 1 via the AGXT Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CNuclearMitome Test

Lab: Transgenomic New Haven, Connecticut, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (386)
Total targets (434)

CPrimary Hyperoxaluria Type 1

Lab: Counsyl South San Francisco, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CHyperoxaluria Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region

CHyperoxaluria type I (AGXT)

Test targets
Methods
  • C Sequence analysis of the entire coding region

CAGXT

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CPeroxisomal Disorders Comprehensive NGS Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (17)
Total targets (24)

CPrimary Hyperoxaluria Type 1

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CAGXT. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNuclear-Mito NGS Panel

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (601)
Total targets (504)

CPrimary hyperoxaluria type 1: AGXT gene sequence analysis

Test targets
Methods
  • C Sequence analysis of the entire coding region

CHyperoxaluria, primary I

Lab: MedGene Bratislava, Bratislava, Slovakia
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 26 tests for 1 condition in 21 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.